Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Document › Details

Danaher Corporation. (3/31/20). "Press Release: Danaher Completes Acquisition Of The Biopharma Business Of General Electric Life Sciences, Business Will Be Called Cytiva". Washington, DC.

Organisations Organisation Danaher Corporation (NYSE: DHR)
  Group Danaher (Group)
  Organisation 2 GE Biopharma
  Today Cytiva (Global Life Sciences Solutions, formerly GE Biopharma business of GE Life Sciences)
  Group Danaher (Group)
Products Product LIFE SCIENCES
  Product 2 laboratory equipment and instruments
Index term Index term General Electric–Danaher: investment, 201902–202003 acquisition $21.4b in cash of biopharma business of GE Life Sciences
Person Person Gugino, Matthew E. (Danaher 201407 VP Investor Relations)
     


Danaher Corporation (NYSE: DHR) ("Danaher") announced today the completion of its acquisition of the Biopharma business from General Electric Company's (NYSE: GE) Life Sciences division. As part of Danaher, the business will be called Cytiva and will be a standalone operating company within Danaher's Life Sciences segment.


ABOUT DANAHER

Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher's globally diverse team of approximately 67,000 associates is united by a common culture and operating system, the Danaher Business System, and its Shared Purpose, Helping Realize Life's Potential. For more information, please visit www.danaher.com.


For further information:

Matthew E. Gugino, Vice President, Investor Relations, Danaher Corporation, 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, D.C. 20037, Telephone: (202) 828-0850, Fax: (202) 828-0860; MEDIA CONTACT: George Sard, Sard Verbinnen & Co, Telephone: (212) 687-8080, Email: gsard@sardverb.com

   
Record changed: 2023-06-05

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Danaher (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top